share_log

Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Management, LP(6.0%),David Salanic(6.0%), etc.

Arbutus Biopharma | SC 13G:超过5%持股股东披露文件-Whitefort Capital Management, LP(6.0%),David Salanic(6.0%)等

SEC announcement ·  2023/09/11 17:07
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息